Differentiation of Amniotic Membrane Mesenchymal Stem Cells to Cardiomyocytes and its Characteristics
Archives of Advances in Biosciences,
Vol. 10 No. 4 (2019),
14 October 2019
,
Page 41-49
https://doi.org/10.22037/aab.v10i4.26617
Abstract
Introduction: Mesenchymal stem cells (MSCs) have high potential in regenerative medicine based on their renewal properties and multilinearity differentiation capacity. MSCs have the ability to differentiate to osteoblasts, adipocytes, chondrocytes, cardiomyocytes, nerve cells, and fibroblasts. These cells have many sources such as bone marrow, umbilical cord blood, and amniotic membrane. Amniotic membrane is a postnatal organ, which does not require an invasive method for procurement. The immunomodulatory properties of MSCs make these cells the primary choice for allotransplantation and xenotransplantation.
Materials and Methods: In this study, MSCs were isolated from the amniotic membrane, and their surface markers were identified using flow cytometry. The cells were differentiated to osteoblasts, adipocytes and cardiomyocytes using differentiation medium. GAP-43 and α-actin were studied with immunofluorescence and the expressions of related genes (GATA-4 and C-TNT) were assayed by real-time polymerase chain reaction.
Results: The results confirmed the differentiation of MCS to cardiomyocytes. The expression level of GATA-4 and C-TNT was higher than that of the control. The results of the present study suggested that differentiated human amniotic MSC possessed some characteristics of cardiomyocytes.
Conclusion: Therefore, according to the results, the amniotic membrane is a suitable source of mesenchymal cells for differentiation into cardiomyocyte cells.
- Amniotic membrane
- Cardiomyocyte
- Mesenchymal stem cells
- GATA-4
- C-TNT
- GAP-43 and α-actin
How to Cite
References
Yusoff N.H, Alshehadat S.A, Azlina A, Kannan T.P, Hamid S.S. A comparison of culture characteristics between human amniotic mesenchymal stem cells and dental stem cells. Tropical Life Sciences Research 2015; 26(1), 21-9.
Caplan A. I. Mesenchymal stem cells: time to change the name! Stem cells translational Medicine 2017; 6(6), 1445-1451.
Salem H.K. and Thiemermann, C. Mesenchymal stromal cells: current understanding and clinical status. Translational Research 2010; 28(3):585–596.
Dizaji Asl K, Shafaei H, Soleimani Rad J, and Nozad H.O. Comparison of characteristics of human amniotic membrane and human adipose tissue derived mesenchymal stem cells. World Journal of Pharmaceutical Sciences 2017; 6(1), 33-39.
Manuelpillai U, Moodley Y, Borlongan C.V, Parolini O. Amniotic membrane and amniotic cells: potential therapeutic tools to combat tissue inflammation and fibrosis? Placenta 2011; 32: S320–5.
Silini A, Parolini O, Huppertz B, Lang I. Soluble factors of amnion-derived cells in treatment of inflammatory and fibrotic pathologies. Current stem cell research therapy 2013; 8:6–14.
Magatti M, Caruso M, De Munari S, Vertua E, De D, Manuelpillai U, Parolini O. Human amniotic membrane-derived mesenchymal and epithelial cells exert different effects on monocyte-derived dendritic cell differentiation and function. Cell Transplantation 2014; 24(9): 1733–1752.
Rossi D, Pianta S, Magatti M, Sedlmayr P, and Parolini O. Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activity. PloS one 2012; 7(10), e46956.
Pianta S, Bonassi Signoroni P, Muradore I, Rodrigues M.F, Rossi D, Silini A, and Parolini O. Amniotic membrane mesenchymal cells-derived factors skew T cell polarization toward Treg and downregulate Th1 and Th17 cells subsets. Stem Cell Reviews and Reports 2014; 11(3), 394-407.
Parolini O, Souza-Moreira L, O'Valle F, Magatti M., Hernandez-Cortes P, Gonzalez-Rey E, Delgado M. Therapeutic effect of human amniotic membrane-derived cells on experimental arthritis and other inflammatory disorders. Arthritis & Rheumatology 2014; 66:327–39.
Dua H.S. and Azuara-Blanco A. Amniotic membrane transplantation. British Journal of Ophthalmology 1999; 83:748–752.
Slack, J.M.W. Essential Developmental Biology. Wiley-Blackwell, Oxford, 2013.
Slack, J.M.W. Metaplasia and trans differentiation: from pure biology to the clinic. Nature Reviews Molecular Cell Biology 2007; 8 (5): 369–378.
Lysaght M.J, Jaklenec A, Deweerd E. Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. Tissue Engineering Part A 2008; 14:305–15.
Rabbani S, Soleimani M, Sahebjam M, Imani M, Nassiri S.M, Atashi A, Daliri Joupari M, Ghiaseddin A, Latifpour M, Ahmadi Tafti S.H. Effects of Endothelial and Mesenchymal Stem Cells on Improving Myocardial Function in a Sheep Animal Model.
Journal of Tehran University Heart Center 2017; 12(2):65-71.
Khatri M, O’Brien D.T, Chattha K.S, Saif L.J. Porcine lung mesenchymal stromal cells possess differentiation and immunoregulatory properties. Stem Cell Research Therapy 2015; 6:222.
Tsai M.S, Lee J.L, Chang Y.J, Hwang S.M. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Molecular Human Reproduction 2004; 19(6): 1450-6.
Tomasello L, Mauceri R., Coppola A, Pitrone M, Pizzo G, Pizzolanti G, Giordano G. Mesenchymal stem cells derived from inflamed dental pulpal and gingival tissue: a potential application for bone formation. Stem Cell Research Therapy 2017; 8:179.
Mu M.W, Zhao Z.Y, Li C.G. Comparative study of neural differentiation of bone marrow mesenchymal stem cells by different induction methods. Genetics and Molecular Research 2015; 14 (4), 14169–14176.
Yong K.W, Li Y, Liu F, Bin Gao Lu, T.J, Wan Abas W.A, Wan Safwani W.K, Pingguan-Murphy B, Ma Y., Xu F, Huang G. Paracrine effects of adipose-derived stem cells on matrix stiffness-induced cardiac myofibroblast differentiation via angiotensin II type 1 receptor and smad7. Science Report 2016; 6:33067.
Bai J, Hu, Y, Wang Y.R, Liu L.F, Chen J, Su S.P, and Wang Y. Comparison of human amniotic fluid-derived and umbilical cord Wharton's Jelly-derived mesenchymal stromal cells: Characterization and myocardial differentiation capacity. Journal of Geriatric Cardiology 2012; 9(2); 166-71.
Yu B, Gong M, Wang Y, Millard R.W, Pasha Z, Yang Y, Ashraf M, Xu M. Cardiomyocyte protection by GATA-4 gene engineered mesenchymal stem cells is partially mediated by translocation of miR-221 in microvesicles. PloS one 2013; 8(8): e73304.
Gaetani R, Ledda M, Barile L, Chimenti I, De Carlo F, Forte E, Ionta V, Giuliani E, Giacomo F, Mirladi D, Pozzi D, Messina E, Grimaldi S, Giacomello A, Lisi A. Differentiation of human adult cardiac stem cells exposed to extremely low-frequency electromagnetic fields. Cardiovascular Research 2009; 82(3): 411-20.
Insausti C.L, Blanquer M, García-Hernández A.M, Castellanos G, and Moraleda J.M. Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application. Stem Cells Cloning 2014; 7: 53-63.
Black B.L, McCulley D.J Transcription factor pathways and congenital heart disease. Current Topics in Developmental Biology 2012; 100: 253–277.
Hatzistergos K.E, Quevedo H, Oskouei B.N, Hu Q, Feigenbaum G.S, Margitich I.S, Mazhari R, Boyle A.J, Zambrano J.P, Rodriguez J.E, Dulce R, Pattany P.M,Valdes D, Revilla C, Heldman A.W, McNiece I, Hare J.M. Circ Res; 2010; 107(7):913-22.
Perrino C, Rockman H.A. GATA4 and the two sides of gene expression reprogramming. Circulation Research 2006; 98: 837-845.
Molkentin J.D. The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. Journal of Biological Chemistry 2000; 25983-94983: 05572.
Maioli M, Contini G, Santaniello S, Bandiera P, Pigliaru G, Sanna R, Rinaldi S, Delitala A. P, Montella A., Bagella L., … Ventura C. Amniotic fluid stem cells morph into a cardiovascular lineage: analysis of a chemically induced cardiac and vascular commitment. Drug Design, Development and Therapy 2013; 7: 1063-73.
Biesiadecki B.J, Chong S.M, Nosek T.M, and Jin J.P. Troponin T core structure and the regulatory NH2-terminal variable region. Biochemistry 2007;46(5): 1368-79.
Ganong's Review of Medical Physiology, 24th Edition. Lange (Tata McGraw Hill). 2012. p. 100.
Atala A, Bauer S.B, Soker S, Yoo J.J, Retik A.B. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006; 367:1241–6.
Szaraz P, Librach M, Maghen L, Iqbal F, Barretto T.A, Kenigsberg S, Gauthier-Fisher A, Librach CL. In Vitro Differentiation of First Trimester Human Umbilical Cord Perivascular Cells into Contracting Cardiomyocyte-Like Cells. Stem Cells International 2016; 2016:7513252.
- Abstract Viewed: 156 times
- PDF Downloaded: 117 times